These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6757153)

  • 21. S-carboxymethylcysteine in the treatment of glue ear: a double blind trial.
    Ramsden RT; Moffat DA; Gibson WP; Jay MM
    J Laryngol Otol; 1977 Oct; 91(10):847-51. PubMed ID: 336818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mucoregulatory therapy in secreting disease of the middle ear].
    Bonci M; Bozzi A
    Minerva Med; 1994 Mar; 85(3):83-7. PubMed ID: 8196848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S-carboxymethylcysteine in otitis media with effusion. (A double-blind study).
    Khan JA; Marcus P; Cummings SW
    J Laryngol Otol; 1981 Oct; 95(10):995-1001. PubMed ID: 7028897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of a purified glycoprotein substance extracted from Klebsiella pneumoniae in the clinical course of acute infections of the airways in patients with chronic bronchitis. Italian Group for the Study of Biological Immunomodulators].
    Recenti Prog Med; 1988 Feb; 79(2):73-8. PubMed ID: 3291026
    [No Abstract]   [Full Text] [Related]  

  • 25. Phyllocontin in chronic airflow obstruction.
    Dunn A; Hoffman N; Wilson RS
    Br J Clin Pract; 1984 Feb; 38(2):63-5. PubMed ID: 6367798
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of oral salbutamol and ephedrine in chronic obstructive pulmonary disease.
    Kamat SR; Hoskote VR; Store SD; Sanghavi B; Sheth UK
    Indian J Chest Dis Allied Sci; 1978 Apr; 20(2):54-62. PubMed ID: 363609
    [No Abstract]   [Full Text] [Related]  

  • 27. A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis.
    Aylward M
    Curr Med Res Opin; 1973; 1(4):219-27. PubMed ID: 4589629
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of S-carboxymethylcysteine lysine salt on mucociliary clearance in rabbits with secretory cell metaplasia.
    Daffonchio L; De Santi MM; Gardi C; Lungarella G; Omini C
    Res Commun Mol Pathol Pharmacol; 1994 Oct; 86(1):59-74. PubMed ID: 7850257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double blind crossover randomised study of bromhexine in chronic obstructive airway disease.
    Misra MP; Tiwari UC; Chaubal CC; Galhotra R
    J Assoc Physicians India; 1984 May; 32(5):423-5. PubMed ID: 6389491
    [No Abstract]   [Full Text] [Related]  

  • 30. Bronchial drainage prior to bronchography--a possible modification.
    Nigam BK
    Thorac Cardiovasc Surg; 1983 Feb; 31(1):49. PubMed ID: 6189253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No demonstrable effect of sobrerol as an expectorant in patients with stable chronic bronchial diseases.
    Medici TC; Shang H; Grosgurin P; Berg P; Achermann R; Wehrli R
    Bull Eur Physiopathol Respir; 1985; 21(6):477-83. PubMed ID: 3907738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thirty-five cases of S-carboxymethylcysteine use in paraquat poisoning.
    Lugo-Vallín N; Maradei-Irastorza I; Pascuzzo-Lima C; Ramírez-Sánchez M; Montesinos C
    Vet Hum Toxicol; 2003 Feb; 45(1):45-6. PubMed ID: 12583701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled clinical trial of a new dosage form of metaproterenol.
    Beck GJ
    Ann Allergy; 1980 Jan; 44(1):19-22. PubMed ID: 6986110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness and tolerance of a new molecule with secreto-dynamic activity: nesosteine].
    Gatto PG; Gramolini C; Valenti S
    Clin Ter; 1989 Jan; 128(2):87-97. PubMed ID: 2523778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new, modified form of inhaler ('Rotahaler') for patients with chronic obstructive lung disease.
    Pover GM; Dash CH
    Pharmatherapeutica; 1985; 4(2):98-101. PubMed ID: 3903783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No demonstrable effect of S-carboxymethylcysteine on clearance of secretions from the human lung.
    Thomson ML; Pavia D; Jones CJ; McQuiston TA
    Thorax; 1975 Dec; 30(6):669-73. PubMed ID: 769242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sobrerol as an expectorant in patients with stable chronic airway diseases: a controlled study].
    Meyer-Shang H; Grosgurin P; Medici TC
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():936-8. PubMed ID: 6359129
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical trial of a new mucolytic, s-carboxymethylcysteine].
    Ghillione de Torviso S
    Arch Argent Pediatr; 1971 Aug; 69(6):247-8. PubMed ID: 4941345
    [No Abstract]   [Full Text] [Related]  

  • 39. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A; Grieco A; Vibelli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.